News Contact Us

FDA suggests the recall of all Zantac drugs from the market

Author : Pankaj Singh | Published Date : 2020-04-03 

America’s federal healthcare agency, the U.S. FDA has recently requested all drug manufacturers to immediately recall all over-the-counter and prescription ranitidine drugs that are commonly sold under the name Zantac from the market. 

According to reliable sources, in its ongoing investigation, the FDA found that the heartburn medications observed a rise in levels of contaminants over time. In addition, when kept under higher-than-normal temperatures, the drug presented a risk to consumer’s health.

Reportedly, the contaminant, which is often categorized as NDMA (N-nitrosodimethylamine), is considered as a potential human carcinogen and the agency has been examining it since the last summer for the levels of it in ranitidine.

Speaking on the matter, Dr. Janet Woodcock, Director of Center for Drug Evaluation and Research, FDA, said that the agency didn’t notice higher levels of NDMA in several previous samples tested earlier. However, since the agency is unaware up to how long the drug will be stored, it has decided that the drug should be out of the patients’ reach unless and until its quality has been assured. 

Moreover, the FDA would amplify its efforts to guarantee that impurities in other medicines do not surpass tolerable limits. This would help patients to continue their medications without any long-term effects, added Woodcock.

As per FDA order, letters are being issued to every ranitidine manufacturer, requesting them to recall products from the stores. Meanwhile, consumers are instructed to stop consuming any ranitidine liquid medications or tablets. The FDA has requested consumers to dispose these drugs properly and refrain from buying more.

In fact, due to the ongoing COVID-19 crisis, the FDA has advised customers not to return these drugs to a "drug take-back region," instead dispose them as per manufacturer’s disposal instructions given in the medication guide. Although, if the drug does not come with a guideline, then users can follow FDA's directives to ensure safe drug disposal.

Source Credit: https://edition.cnn.com/2020/04/01/health/zantac-fda-remove-from-market-bn/index.html

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Kotak Bank gears up to launch a major share sale worth $2 billion

Published Date: 2020-05-27         Author: Pankaj Singh

Renowned financial institution Kotak Mahindra Bank has apparently made it to the headlines for its announcement of planning to launch a share sale to institutional investors. Reliable reports affirm that this share sale has been targeted toward raising as much as $2 billion in multiple tranches, in ... Read More

Canadian Competition Bureau fines Facebook $9 million for false claims

Published Date: 2020-05-22         Author: Pankaj Singh

Social media giant, Facebook Inc., has been witnessing a never-ending deluge of privacy and security related scandals over the past few years. Recently, the company made headlines when Canada’s Competition Bureau has fined the social media giant USD 9 million for making misleading or false cla... Read More

Sika starts manufacturing safety masks after hand sanitizers

Published Date: 2020-05-20         Author: Pankaj Singh

  Sika has started producing safety masks for its employees and customers These face masks have polyester-based protective layers 50,000 masks have been produced till date and 165,000 more have been pre-ordered Swiss chemical specialty major Sika has reportedly commenced the prod... Read More

© 2020 Fractovia. All Rights Reserved